Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar A Santa-Maria

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Oncotarget|December 8, 2016
Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsRicardo Costa, Cesar A Santa-Maria, Giovanna Rossi, et al.
Royal Society Open Science|June 21, 2019
<i>In silico</i> simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology modelHanwen Wang, Oleg Milberg, Imke H Bartelink, et al.
Journal for Immunotherapy of Cancer|February 16, 2020
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancerAmi N Shah, Lisa Flaum, Irene Helenowski, et al.
Breast Cancer Research and Treatment|November 13, 2020
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancerEric Xie, Maya M Lapinski, Sarah Talamantes, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 2024
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockadeTheinmozhi Arulraj, Hanwen Wang, Atul Deshpande, et al.
Breast Cancer Research and Treatment|July 29, 2017
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centersCesar A Santa-Maria, Megan Kruse, Paola Raska, et al.
Clinical Breast Cancer|February 13, 2019
Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast CancerElisavet Paplomata, Amelia Zelnak, Cesar A Santa-Maria, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockadeTheinmozhi Arulraj, Hanwen Wang, Atul Deshpande, et al.
Oncotarget|March 24, 2016
Genomic landscape of DNA repair genes in cancerYoung Kwang Chae, Jonathan F Anker, Benedito A Carneiro, et al.
Cancer Treatment Reviews|January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug developmentRicardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Oncotarget|December 8, 2016
Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsRicardo Costa, Cesar A Santa-Maria, Giovanna Rossi, et al.
Royal Society Open Science|June 21, 2019
<i>In silico</i> simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology modelHanwen Wang, Oleg Milberg, Imke H Bartelink, et al.
Journal for Immunotherapy of Cancer|February 16, 2020
Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2-negative endocrine-refractory metastatic breast cancerAmi N Shah, Lisa Flaum, Irene Helenowski, et al.
Breast Cancer Research and Treatment|November 13, 2020
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancerEric Xie, Maya M Lapinski, Sarah Talamantes, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 2024
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockadeTheinmozhi Arulraj, Hanwen Wang, Atul Deshpande, et al.
Breast Cancer Research and Treatment|July 29, 2017
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centersCesar A Santa-Maria, Megan Kruse, Paola Raska, et al.
Clinical Breast Cancer|February 13, 2019
Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast CancerElisavet Paplomata, Amelia Zelnak, Cesar A Santa-Maria, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockadeTheinmozhi Arulraj, Hanwen Wang, Atul Deshpande, et al.
Oncotarget|March 24, 2016
Genomic landscape of DNA repair genes in cancerYoung Kwang Chae, Jonathan F Anker, Benedito A Carneiro, et al.
Cancer Treatment Reviews|January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug developmentRicardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Pageof 6